Treatments of CD19/20/22 CAR T cells showed significant anti-tumour response in both mouse models with CD19+ B-ALL as well as the CD19− escape B-ALL which CD19 CAR T cells was ineffective at treating alone [24]. The gene discussed is CD19; the disease is neoplasm.